Advertisement

Topics

Search Results for "Galderma Company Rpofile"

18:29 EST 26th February 2017 | BioPortfolio

Matching Channels

Medtronic

With annual sales reaching $15 billion in 2010, Medtronic is the 4th largest medical devices company in the world (based on annual sales). The device portfolio of Medtronic is broad; covering card...

The Top 100 Drugs

The pharmaceutical industry is massive, both in range of products and in financial values. These are the top 200 drugs (ranked in descending order according to total sales in 20010, $), and the co...

MediciGlobal is a specialty patient recruitment-retention organization serving the clinical trials industry

MediciGlobal is a specialty patient recruitment-retention organization serving the clinical trials industry. For more than two decades, the company has led the industry in developing innovative p...

Datamonitor - aims to help its clients operating in the pharmaceuticals, healthcare and biotechnology fields, offering world-leading products and services to meet the challenges of this rapidly evolving marketplace

The Datamonitor Group aims to help its clients operating in the pharmaceuticals, healthcare and biotechnology fields, offering world-leading products and services to meet the challenges of this rapi...

Rivaroxaban

Rivaroxaban is the most broadly indicated novel oral anticoagulant and is marketed under the brand name Xarelto®. To date, Xarelto has been approved for use in the following indications across t...

Matching News

Galderma S.A. Mergers Acquisitions MA, Partnerships Alliances and Investment Report Prices from USD $350

SummaryMarketLine's Company Mergers Acquisitions MA, Partnerships Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an orga...

Market Research Proves Success of Galderma’s Harmony Programme for Aesthetic Practice

For additional information:GaldermaMårten Forrest, +46 768 98 1106Head of PR & CommunicationAesthetic & Corrective Businessmarten.forrest@galderma.com Read more...

Galderma Laboratories, Inc. Mergers Acquisitions MA, Partnerships Alliances and Investment Report Prices from USD $350

SummaryMarketLine's Company Mergers Acquisitions MA, Partnerships Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an orga...

Galderma's dermal fillers for facial wrinkles approved by FDA

The FDA has approved the use of Galderma's dermal fillers Restylane Defyne to treat moderate to severe deep facial wrinkles a -More- 

Bioventus enters new agreement for single-injection HA product

Bioventus announced its new agreement with Galderma for Durolane, a single-injection hyaluronic acid product for joint lubrication in the treatment of symptomatic patients with knee osteoarthritis.  ...

Bioventus, Galderma deal

Galderma to Share Data from Phase 3 Studies of New Investigational Restylane® Refyne and Restylane® Defyne at American Society for Dermatologic Surgery Annual Meeting

NEW ORLEANS, Nov. 10, 2016 /PRNewswire/ -- Galderma, a global leader focused on medical solutions in skin health, will share data from two pivotal Phase 3 clinical studies investigating Rest...

Galderma Laboratories Release: Differin Gel Acne Treatment Partners With Actress To End Adult Acne Frustrations For Millions Of Sufferers

  Life Sciences Jobs   ...

Matching PubMed Articles

Search Whole site using Google

Loading
Quick Search
Advertisement
 
Advertisement Advertisement